These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34800721)

  • 1. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C.
    Golabi P; Paik JM; Eberly K; de Avila L; Alqahtani SA; Younossi ZM
    Ann Hepatol; 2022; 27(1):100556. PubMed ID: 34800721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.
    Kim D; Adejumo AC; Yoo ER; Iqbal U; Li AA; Pham EA; Cholankeril G; Glenn JS; Ahmed A
    Gastroenterology; 2019 Oct; 157(4):1055-1066.e11. PubMed ID: 31251928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
    Kim D; Li AA; Gadiparthi C; Khan MA; Cholankeril G; Glenn JS; Ahmed A
    Gastroenterology; 2018 Oct; 155(4):1154-1163.e3. PubMed ID: 30009816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
    Stepanova M; Rafiq N; Younossi ZM
    Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
    Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
    Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.
    Munteanu M; Pais R; Peta V; Deckmyn O; Moussalli J; Ngo Y; Rudler M; Lebray P; Charlotte F; Thibault V; Lucidarme O; Ngo A; Imbert-Bismut F; Housset C; Thabut D; Ratziu V; Poynard T;
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1117-1127. PubMed ID: 30334263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry).
    Burra P; Senzolo M; Adam R; Delvart V; Karam V; Germani G; Neuberger J; ;
    Am J Transplant; 2010 Jan; 10(1):138-48. PubMed ID: 19951276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past exposure to hepatitis B: a risk factor for increase in mortality?
    Jinjuvadia R; Liangpunsakul S; Antaki F
    J Clin Gastroenterol; 2014 Mar; 48(3):267-71. PubMed ID: 23751854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.
    Alqahtani SA; Yilmaz Y; El-Kassas M; Alswat K; Sanai F; AlZahrani M; Abaalkhail F; AlShaikh M; Al-Hamoudi WK; Nader F; Stepanova M; Younossi ZM;
    J Viral Hepat; 2024 Jun; 31(6):300-308. PubMed ID: 38622910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States.
    Paik JM; Golabi P; Biswas R; Alqahtani S; Venkatesan C; Younossi ZM
    Hepatol Commun; 2020 Jun; 4(6):890-903. PubMed ID: 32490324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
    Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiologies of chronic liver diseases in Hong Kong.
    Fung KT; Fung J; Lai CL; Yuen MF
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):659-64. PubMed ID: 17625435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deaths from chronic liver disease and viral hepatitis, Multnomah County, Oregon, 2000.
    Thomas AR; Zaman A; Bell BP
    J Clin Gastroenterol; 2007 Oct; 41(9):859-62. PubMed ID: 17881933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.
    Setiawan VW; Stram DO; Porcel J; Lu SC; Le Marchand L; Noureddin M
    Hepatology; 2016 Dec; 64(6):1969-1977. PubMed ID: 27301913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease.
    Hong YS; Sinn DH; Gwak GY; Cho J; Kang D; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    World J Gastroenterol; 2016 Apr; 22(14):3785-92. PubMed ID: 27076763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
    Hassan I; Gane E
    Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.